Page last updated: 2024-10-30

ketotifen and Duodenal Ulcer

ketotifen has been researched along with Duodenal Ulcer in 1 studies

Ketotifen: A cycloheptathiophene blocker of histamine H1 receptors and release of inflammatory mediators. It has been proposed for the treatment of asthma, rhinitis, skin allergies, and anaphylaxis.
ketotifen : An organic heterotricyclic compound that is 4,9-dihydro-10H-benzo[4,5]cyclohepta[1,2-b]thiophen-10-one which is substituted at position 4 by a 1-methylpiperidin-4-ylidene group. A blocker of histamine H1 receptors with a stabilising action on mast cells, it is used (usually as its hydrogen fumarate salt) for the treatment of asthma, where it may take several weeks to exert its full effect.

Duodenal Ulcer: A PEPTIC ULCER located in the DUODENUM.

Research Excerpts

ExcerptRelevanceReference
"Ketotifen is an anti-allergic agent that was recently shown to prevent experimental gastric and colonic mucosal injury."1.29Ketotifen is protective against indomethacin-induced intestinal ulceration in the rat. ( Dinari, G; Karmeli, F; Marcus, H; Weizen, T; Zahavi, I, 1996)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zahavi, I1
Weizen, T1
Marcus, H1
Karmeli, F1
Dinari, G1

Other Studies

1 other study available for ketotifen and Duodenal Ulcer

ArticleYear
Ketotifen is protective against indomethacin-induced intestinal ulceration in the rat.
    Israel journal of medical sciences, 1996, Volume: 32, Issue:5

    Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Dinoprostone; Disease Models

1996